# Status de Autoriza√ß√£o Regulat√≥ria Brasil - BRIG - Guia de Implementa√ß√£o Brasileiro para IDMP v0.0.3

* [**Table of Contents**](toc.md)
* [**Artifacts Summary**](artifacts.md)
* **Status de Autoriza√ß√£o Regulat√≥ria Brasil**

## ValueSet: Status de Autoriza√ß√£o Regulat√≥ria Brasil (Experimental) 

| | |
| :--- | :--- |
| *Official URL*:http://farmaco.maxapex.net/brig/fhir/ValueSet/regulated-authorization-status-br | *Version*:0.0.3 |
| *Standards status:*[Informative](http://hl7.org/fhir/R5/versions.html#std-process) | *Computable Name*:RegulatedAuthorizationStatusBR |
| **Copyright/Legal**: Copyright ¬© 2025 Farmaco.io. Este trabalho est√° licenciado sob a MIT License. FHIR¬Æ √© marca registrada da HL7 International, usada com permiss√£o. | |

 
Conjunto de valores para status de autoriza√ß√µes regulat√≥rias ANVISA 

 **References** 

Este conjunto de valores n√£o √© utilizado aqui; pode ser utilizado noutro local (por exemplo, especifica√ß√µes e/ou implementa√ß√µes que utilizem este conte√∫do)

### Logical Definition (CLD)

* Include todos os c√≥digos definidos em [`http://farmaco.maxapex.net/brig/fhir/CodeSystem/regulated-authorization-status-br`](CodeSystem-regulated-authorization-status-br.md)vers√£o üì¶0.0.3

¬†

### Expansion

Expans√£o efectuada internamente com base em [codesystem Status de Autoriza√ß√£o Regulat√≥ria ANVISA v0.0.3 (CodeSystem)](CodeSystem-regulated-authorization-status-br.md)

Este conjunto de valores cont√©m 10 conceitos

-------

 Explanation of the columns that may appear on this page: 

| | |
| :--- | :--- |
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the*display*element of a[Coding](http://hl7.org/fhir/R5/datatypes.html#Coding)). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |



## Resource Content

```json
{
  "resourceType" : "ValueSet",
  "id" : "regulated-authorization-status-br",
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode" : "informative",
      "_valueCode" : {
        "extension" : [
          {
            "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical" : "https://idmp-br.github.io/brig-idmp-brasil/ImplementationGuide/brig.idmp.brazil"
          }
        ]
      }
    }
  ],
  "url" : "http://farmaco.maxapex.net/brig/fhir/ValueSet/regulated-authorization-status-br",
  "version" : "0.0.3",
  "name" : "RegulatedAuthorizationStatusBR",
  "title" : "Status de Autoriza√ß√£o Regulat√≥ria Brasil",
  "status" : "draft",
  "experimental" : true,
  "date" : "2025-09-07",
  "publisher" : "IDMP Brasil",
  "contact" : [
    {
      "name" : "IDMP Brasil",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://idmp-br.github.io"
        },
        {
          "system" : "email",
          "value" : "eugenio@farmaco.io"
        }
      ]
    },
    {
      "name" : "IDMP Brasil",
      "telecom" : [
        {
          "system" : "email",
          "value" : "eugenio@farmaco.io"
        },
        {
          "system" : "url",
          "value" : "https://idmp-br.github.io/brig-idmp-brasil"
        }
      ]
    }
  ],
  "description" : "Conjunto de valores para status de autoriza√ß√µes regulat√≥rias ANVISA",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "BR"
        }
      ]
    }
  ],
  "copyright" : "Copyright ¬© 2025 Farmaco.io. Este trabalho est√° licenciado sob a MIT License. FHIR¬Æ √© marca registrada da HL7 International, usada com permiss√£o.",
  "compose" : {
    "include" : [
      {
        "system" : "http://farmaco.maxapex.net/brig/fhir/CodeSystem/regulated-authorization-status-br"
      }
    ]
  }
}

```
